Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy

被引：28

作者：

Vengalil, Salil ^{[1
,6
]}

Giuliani, Meredith E. ^{[1
]}

Huang, Shao Hui ^{[1
]}

McNiven, Andrea ^{[2
]}

Song, Yuyao ^{[3
]}

Xu, Wei ^{[3
]}

Chan, Biu ^{[1
]}

Hope, Andrew ^{[1
]}

Cho, John ^{[1
]}

Bayley, Andrew ^{[1
]}

Ringash, Jolie ^{[1
]}

Goldstein, David ^{[4
]}

Razak, Albiruni ^{[5
]}

Irish, Jonathan ^{[4
]}

Gilbert, Ralph ^{[4
]}

Gullane, Patrick ^{[4
]}

Waldron, John ^{[1
]}

Kim, John ^{[1
]}

O'Sullivan, Brian ^{[1
]}

机构：

[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada

[2] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Phys, Toronto, ON, Canada

[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada

[4] Univ Toronto, Princess Margaret Canc Ctr, Dept Otolaryngol Head & Neck Surgery Surg Oncol, Toronto, ON, Canada

[5] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON, Canada

[6] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Dept Clin Oncol, Stoke On Trent, Staffs, England

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷

关键词：

laryngeal carcinoma; chemoradiotherapy; laryngectomy; organ preservation; Dosimetric analysis; QUALITY-OF-LIFE; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TUMOR VOLUME; DEFINITIVE RADIOTHERAPY; NONSURGICAL TREATMENT; COMPUTED-TOMOGRAPHY; NECK; CHEMOTHERAPY; PREDICTOR;

D O I：

10.1002/hed.24374

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Background. The purpose of this study was to determine the clinical outcomes of T4 laryngeal cancers. Methods. T4 laryngeal cancers treated with curative intent from January 2003 to December 2010 were analyzed. Outcomes were evaluated in both primary radiotherapy (+/- chemotherapy) (RT/CRT) and primary surgery cohorts. Results. Among the 65 primary RT/CRT and 42 primary surgery patients included, median follow-up was 4.4 years. There was a trend for improved locoregional control with surgery (74% vs 88%; p = .08). In the RT/CRT group the 3-year laryngectomy-free survival was 67%. The 2-year gastrostomy dependency rate was 23% with RT/CRT versus 6% with primary surgery (p = .07). Overall survival (OS) at 3 years was significantly lower in the RT/CRT versus primary surgery group (41% vs 70%; p < .01). Conclusion. Laryngeal preservation is achieved in over two thirds of patients with primary RT/CRT. Patients with low volume minimal cartilage involvement T4 disease may be best suited to RT/CRT. (C) 2016 Wiley Periodicals, Inc.

引用

页码：E2035 / E2040

页数：6

共 25 条

[11] Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A Phase II trial of the Radiation Therapy Oncology Group (RTOG 99-14)
Garden, Adam S.
Harris, Jonathan
Trotti, Andy
Jones, Christopher U.
Carrascosa, Luis
Cheng, Jonathan D.
Spencer, Sharon S.
Forastiere, Arlene
Weber, Randal S.
Ang, K. Kian
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1351 - 1355
[12] Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes
Grover, Surbhi
Swisher-McClure, Samuel
Mitra, Nandita
Li, Jiaqi
Cohen, Roger B.
Ahn, Peter H.
Lukens, John N.
Chalian, Ara A.
Weinstein, Gregory S.
O'Malley, Bert W., Jr.
Lin, Alexander
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (03): : 594 - 601
[13] Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Haddad, Robert
O'Neill, Anne
Rabinowits, Guilherme
Tishler, Roy
Khuri, Fadlo
Adkins, Douglas
Clark, Joseph
Sarlis, Nicholas
Lorch, Jochen
Beitler, Jonathan J.
Limaye, Sewanti
Riley, Sarah
Posner, Marshall
[J]. LANCET ONCOLOGY, 2013, 14 (03) : 257 - 264
[14] Laryngeal tumor volume as a predictor for thyroid cartilage penetration
Kats, Svetlana S.
Muller, Susan
Aiken, Ashley
Hudgins, Patricia A.
Wadsworth, J. Trad
Shin, Dong M.
Khuri, Fadlo
Beitler, Jonathan J.
[J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 426 - 430
[15] Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Lorch, Jochen H.
Goloubeva, Olga
Haddad, Robert I.
Cullen, Kevin
Sarlis, Nicholas
Tishler, Roy
Tan, Ming
Fasciano, John
Sammartino, Daniel E.
Posner, Marshall R.
[J]. LANCET ONCOLOGY, 2011, 12 (02) : 153 - 159
[16] Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma
Mancuso, AA
Mukherji, SK
Schmalfuss, I
Mendenhall, W
Parsons, J
Pameijer, F
Hermans, R
Kubilis, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 631 - 637
[17] Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer
Mendenhall, William M.
Mancuso, Anthony A.
Strojan, Primoz
Beitler, Jonathan J.
Suarez, Carlos
Lee, Tsair-Fwu
Langendijk, Johannes A.
Corry, June
Eisbruch, Avraham
Rinaldo, Alessandra
Ferlito, Alfio
[J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (09): : 1363 - 1367
[18] Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy
Mouw, Kent W.
Solanki, Abhishek A.
Stenson, Kerstin M.
Witt, Mary Ellyn
Blair, Elizabeth A.
Cohen, Ezra E. W.
Vokes, Everett E.
List, Marcy
Haraf, Daniel J.
Salama, Joseph K.
[J]. ORAL ONCOLOGY, 2012, 48 (10) : 1025 - 1030
[19] Tumor volume: An independent predictor of outcome for laryngeal cancer
Mukherji, SK
O'Brien, SM
Gerstle, RJ
Weissler, M
Shockley, W
Castillo, M
[J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1999, 23 (01) : 50 - 54
[20] Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
Overgaard, J
Hansen, HS
Specht, L
Overgaard, M
Grau, C
Andersen, E
Bentzen, J
Bastholt, L
Hansen, O
Johansen, J
Andersen, L
Evensen, JF
[J]. LANCET, 2003, 362 (9388) : 933 - 940

← 1 2 3 →